This study aims to explore the effectiveness and safety of a combination treatment involving Xtressé™ supplement and serum to promote hair growth in women who feel they have thinning hair. Women between the ages of 28 to 65 who have noticed a decrease in their hair thickness are eligible to participate. This research is important because it could provide a new solution for women experiencing this common issue, potentially improving their quality of life and self-confidence if the treatment proves to be successful. Participants in the study will need to provide personal and medical information, undergo certain medical exams, and follow specific guidelines throughout the study. They will apply the serum and consume a gummy treatment each day, keeping a diary of their treatment routine. Clinical assessments will involve photographs and measurements of hair density, focusing on a marked area on the scalp. The study also requires participants to avoid other hair treatments and maintain their current hair care routine. Participants are free to leave the study at any time if they choose.
Inclusion Criteria: * Female adults between 28-65 years of age with consistent self-perceived thinning hair. * Ludwig Scale I or II (mild to moderate thinning hair loss), assessed clinically. * Fitzpatrick Skin Types I to VI. * Agree to maintain their current diet, medications, exercise routines, hair shampooing, and color treatment frequency for the duration of the study. * Ability and willingness to comply with the study protocol including regular visits and product application. * Written informed consent obtained, including written consent to allow photographs to be used as part of the study data and documentation. * For females of childbearing potential, a negative pregnancy test at screening and commitment to effective contraception throughout the study (oral / implant/ injectable/ transdermal contraceptives, intrauterine device, condom, diaphragm, abstinence, or a monogamous relationship with a partner who has had a vasectomy) to avoid pregnancy-related hormonal changes affecting hair density. Exclusion Criteria: * Pregnant or lactating or planning to become pregnant. * Changes in hormonal therapy within 6 months prior to enrollment and throughout the study. * Use of other medical hair loss treatments (e.g., Minoxidil, Dutasteride, Finasteride, laser or light therapy) within 3 months prior to study start and throughout the study. * Micro-needling, PRP, or any other physical treatment modality on the scalp (within 6 months prior to study start and throughout the study). * Use of GLP-1 inhibitors (e.g., Semaglutide) within 6 months prior to study start and throughout the study. * Known uncontrolled health conditions (e.g., thyroid disease, anemia) that could confound study outcomes. * Known sensitivity to any of the ingredients in the study medication. * In the investigator's opinion, evidence of unwillingness, or inability to follow the restrictions and requirements of the protocol and complete the study. * Subject has any conditions, findings in history, physical exam or laboratory assessments, which in the opinion of the investigator, would exclude the subject from continuing in this study. * Treatment with an experimental drug, biologic or device within 12 weeks of the screening visit.
are designated in this study
of being blinded to the placebo group